A method to prevent inhibit or treat one or more symptoms associated with disease of the central nervous system by intranasally intrathecally intracerebrovascularly or intravenously administering a rAAV encoding a gene product associated with the disease e.g. a mammal in which the gene product is absent or present at a reduced level relative to a mammal without the disease in an amount effective e.g. to provide for cross correction.
